Conclusions: In patients who progressed following an initial
response to the induction course of therapy, the disease control rate in
the ipilimumab arms was 65%-75% compared to 0% in the gp100 arm upon
re-induction. These findings may have implications for the use of
ipilimumab therapy in the long-term management of advanced melanoma.... (Ipilimumab is the drug Bobby is getting in the clinical trial)
response to the induction course of therapy, the disease control rate in
the ipilimumab arms was 65%-75% compared to 0% in the gp100 arm upon
re-induction. These findings may have implications for the use of
ipilimumab therapy in the long-term management of advanced melanoma.... (Ipilimumab is the drug Bobby is getting in the clinical trial)
1 comment:
Bobby is feeling quite tired lately. Normal things are slowing him down. His appetite is good. We're trying to pamper him and help him get stuff done so he isn't stressing himself over things like getting the newspaper :)
The lung tumors are responding well to the Ipilimumab! If we can maintain that--happy days!
Post a Comment